AISHA HASSAN-DAVIS: Open Payments
NPI 1053951004 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 36 payments from 12 companies in 2025. Trend: 2023 $554 · 2024 $430 · 2025 $994
Food & beverage: $994
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $272 |
| Axsome Therapeutics, Inc. | 3 | $163 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $150 |
| ABBVIE INC. | 5 | $105 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
| Alkermes, Inc. | 2 | $39 |
| Indivior Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
| Lundbeck LLC | 1 | $22 |
Products named: INVEGA SUSTENNA, Auvelity, TRINTELLIX, VRAYLAR, ABILIFY MAINTENA, Qelbree, ARISTADA, SUBLOCADE.
Industry payments across MD — which companies pay providers there.
